Expired Canadian patentCanada
Monoclonal antibodies to the human ldl receptor, their production and use
CA 2402593 C · Owner: Applied Research Systems Ars Holding N.V. · Inventors: Dreano, Michel; Belzer, Ilana; Smolarsky, Moshe
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
There are provided monoclonal antibodies to the human LDL receptor which are useful for the identification and purification of LDL and in treatment of e.g. hepatitis C infection.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 8, 2001 and granted July 3, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 8, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 8, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMarch 8, 2001
GrantedJuly 3, 2012
Term endedMarch 8, 2021
Patent numberCA 2402593 C
Classification (IPC)C07K16/28 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.